Preferred Label : elexacaftor, ivacaftor, tezacaftor drug combination;
CISMeF synonym : elexcaftor, ivacaftor, tezacaftor drug combination;
MeSH synonym : elexacaftor- ivacaftor- tezacaftor drug combination; elexacaftor, ivacaftor, tezacaftor;
Origin ID : C000706587;
UMLS CUI : C5209991;
ATC code(s)
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2024
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information
---
https://www.has-sante.fr/jcms/p_3460573/fr/kaftrio-ivacaftor-/-tezacaftor-/-elexacafto-en-association-avec-kalydeco-mucoviscidose-enfant-6-ans
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug therapy, combination
drug combinations
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
ivacaftor
tezacaftor
guidelines for drug use
evaluation of the transparency committee
child
cystic fibrosis
---
https://www.has-sante.fr/jcms/p_3327002/fr/kaftrio-ivacaftor-/-tezacaftor-/-elexacafto-en-association-avec-kalydeco-mucoviscidose
https://www.has-sante.fr/jcms/p_3327010/fr/decision-n-2022-0178/dp/sem-du-28-mars-2022-de-la-presidente-de-la-haute-autorite-de-sante-prise-au-nom-du-college-portant-autorisation-d-acces-precoce-de-la-specialite-kaftrio
2022
false
false
false
France
drug therapy, combination
drug combinations
administration, oral
ivacaftor, tezacaftor and elexacaftor
Product containing only elexacaftor and ivacaftor and tezacaftor in oral dose form
(medicinal product form)
ivacaftor
tablets
legislation
guidelines for drug use
child
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
ivacaftor
tezacaftor
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
continuity of patient care
forms
professional role
evaluation of the transparency committee
cystic fibrosis
---
https://www.has-sante.fr/jcms/p_3343179/fr/kaftrio-elexacaftor/-ivacaftor/-tezacaftor-mucoviscidose
2022
false
false
false
France
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
elexacaftor
insurance, health, reimbursement
treatment outcome
administration, oral
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
drug combinations
ivacaftor, tezacaftor and elexacaftor
CFTR delta F508
evaluation of the transparency committee
tezacaftor
cystic fibrosis
---
https://www.has-sante.fr/jcms/p_3302605/fr/kalydeco-150-mg-ivacaftor
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug therapy, combination
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
elexacaftor
tezacaftor
ivacaftor
ivacaftor, tezacaftor and elexacaftor
administration, oral
cystic fibrosis
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
evaluation of the transparency committee
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-d6182e9e12-99.html
2021
false
false
false
Canada
French
drug evaluation
quebec
cystic fibrosis
adolescent
adult
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
CFTR delta F508
drug combinations
trikafta
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor, ivacaftor, tezacaftor drug combination
benzodioxoles
aminophenols
indoles
pyrazoles
pyridines
quinolines
benzodioxoles
aminophenols
drug combinations
indoles
pyrazoles
pyridines
quinolines
---
https://www.has-sante.fr/jcms/p_3303740/fr/kaftrio-75-mg/50-mg/100-mg-elexacaftor/-ivacaftor/-tezacaftor
2021
false
false
false
France
CFTR delta F508
elexacaftor
ivacaftor
tezacaftor
drug combinations
treatment outcome
insurance, health, reimbursement
administration, oral
cystic fibrosis
cystic fibrosis
adolescent
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
ivacaftor, tezacaftor and elexacaftor
evaluation of the transparency committee
elexacaftor, ivacaftor, tezacaftor drug combination
---
https://www.ema.europa.eu/en/medicines/human/EPAR/kaftrio
2020
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Product containing only elexacaftor and ivacaftor and tezacaftor in oral dose form
(medicinal product form)
drug approval
europe
drug combinations
administration, oral
orphan drug production
pyrazoles
pyrazoles
pyridines
pyridines
pyrrolidines
pyrrolidines
ivacaftor
ivacaftor
tezacaftor
tezacaftor
adolescent
adult
cystic fibrosis
drug therapy, combination
cystic fibrosis transmembrane conductance regulator
ivacaftor, tezacaftor and elexacaftor
product surveillance, postmarketing
drug interactions
drug evaluation, preclinical
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
elexacaftor
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance
regulator gene
aminophenols
quinolones
aminophenols
quinolones
indoles
benzodioxoles
indoles
benzodioxoles
quinolines
quinolines
---
https://www.has-sante.fr/jcms/p_3220388/fr/kaftrio-/-kalydeco
2020
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
ivacaftor
Chloride Channel Agonists
tezacaftor
ivacaftor
ivacaftor, tezacaftor and elexacaftor
cystic fibrosis
adolescent
adult
CFTR delta F508
cystic fibrosis transmembrane conductance regulator delta F508
administration, oral
elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
evaluation of the transparency committee
aminophenols
quinolones
indoles
benzodioxoles
cystic fibrosis transmembrane conductance regulator
pyrrolidines
pyridines
pyrazoles
drug combinations
quinolines
---
